2026-2027 Product Guide
New research model pricing is now available!
welfareplus+
Enrichment: Elevating
Lab Animal Care
Maximize animal well-being and research
quality with our enrichment solutions.
Hypertension Models.
Clearer Insights.
Get our free guide to translational models that
deliver reliable data and de-risk decisions early.
Monoclonal antibody
production
Secure your source for quality antibody
production. Learn how our experience and
flexibility can meet your needs for both small
scale and large scale production.
Digital Pathology
Learn how our whole slide imaging and
precision AI-driven quantitative image analysis
can support your drug discovery and
development projects.
Assays in Focus
Developing Antibody Drug Conjugate (ADC)
therapeutics? Inotiv has mass spectrometry
assays to quantify your ADC target protein in
any sample type, including FFPE tissue, without
antibodies. We have developed assays to 27
ADC targets for oncology and other therapeutic
applications.
Expect More From Your Discovery, Development and
Research Models Partner
General Toxicology
General Toxicology
Inotiv offers a range of general toxicology studies to evaluate the safety of drugs, medical devices, and other chemicals. We design and conduct studies according to international regulations and our toxicology expertise can help assess potential risks and ensure the safety of your product.
Histology
Histology
Projects with a wide range of services. From tissue processing to digital analysis, our team delivers the quality you expect.
Pathology
Pathology
Access world-class anatomical, clinical, and medical device pathology services, from routine histochemistry, IHC, IF, and ISH to stereology.
Drug Metabolism and Pharmacokinetics (DMPK)
Drug Metabolism and Pharmacokinetics (DMPK)
Whatever you need, from method development to metabolite ID, our phase-appropriate bioanalytical services help you analyze, answer, and advance.
Clinical Bioanalysis
Clinical Bioanalysis
We offer customized end-to-end bioanalytical solutions to achieve your milestones effectively and on schedule, supporting the development of a wide range of therapeutics from first in human to clinical approval.
Research Models
Research Models
Paired with the most comprehensive range of research models in the industry, we offer the experience, animal welfare, quality, and consistency that is essential to your success.
Research Model Services
Research Model Services
Our research model services group provides high-quality support services worldwide, including genetically engineered models and services (GEMS), contract breeding services, surgical services, and more.
Teklad Diet and Bedding
Teklad Diet and Bedding
What comes out of your research depends in large part on what goes into your research models. Ensuring models have the most appropriate laboratory animal diet, bedding, and enrichment is critical to maintaining consistent, reliable data.
Explore Our Full Offering of Services and Products
Discovery and Development
Inotiv delivers a broad array of nonclinical and analytical services from discovery through clinical development.
Research Models and Services
Inotiv provides the broadest range of research models and related services to pharmaceutical and biotech companies, government, academia, and other life science organizations.
The Latest From Inotiv
Thursday, October 8, 2026 11:00 am EDT On-Demand Webinar Move Beyond Static Routines Environmental enrichment is a cornerstone of non-human primate (NHP) care, designed to promote...
October 25-29, 2026 Houston, TX Booth #1716 Each fall since 1950, the American Association for Laboratory Animal Science has held its annual National Meeting. During the five days of...
November 14-18, 2026 Washington, D.C. Booth #937 Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has...
November 15-18, 2026 San Antonio, TX Booth #311 ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract...
July 20, 2026 Inotiv Successfully Completes Financial Restructuring Process Emerges from Chapter 11 with a stronger balance sheet, well...
July 14, 2026 Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved...
June 3, 2026 Receives commitments for $65 million in new money financing to support ongoing business operations Recapitalization...
February 13, 2026
ON-DEMAND WEBINAR
Breaking Barriers: Choosing the Right Partner for Large-Scale Rederivation Success
Undertaking a large-scale rederivation project can be complex and resource-intensive, with hundreds of animal lines at stake. Choosing the...
SCIENTIFIC POSTER
Comparative Evaluation of Different Plating Methodologies and Sources of Induced S9 Metabolic Activation on the Mutagenic Potential of N-Nitrosodipropylamine Using the Ames Test
Due to the current FDA concern and guidance on reducing the risk of Nitrosamine impurities in human drugs, there has been an increased...
Subscribe to updates for Inotiv
Sign up and you'll receive the latest updates that matter to you, delivered straight to your inbox.
SUBSCRIBE NOW